| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.7727 | 
      | Human Intestinal Absorption | HIA- | 0.8854 | 
      | Caco-2 Permeability | Caco2- | 0.8478 | 
      | P-glycoprotein Substrate | Non-substrate | 0.5946 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.7601 | 
                                                     | Non-inhibitor | 0.9392 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.8108 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.7518 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.8797 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.8503 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.6407 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.9306 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.9287 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.9235 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.8404 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.9307 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8959 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9522 | 
                                                                    | Non-inhibitor | 0.8949 | 
      | AMES Toxicity | Non AMES toxic | 0.8864 | 
      | Carcinogens | Non-carcinogens | 0.9529 | 
      | Fish Toxicity | High FHMT | 0.7679 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.8296 | 
      | Honey Bee Toxicity | High HBT | 0.7650 | 
      | Biodegradation | Not ready biodegradable | 0.8749 | 
      | Acute Oral Toxicity | III | 0.4497 | 
      | Carcinogenicity (Three-class) | Non-required | 0.6934 |